Gilead Sciences, the U.S. drugmaker whose antiviral remdesivir has shown promise for treating coronavirus, has in recent weeks been targeted by hackers with ties to Iran, according to a report by skleb1234
that staff at Gilead have recently been subject to attacks from Iranian-linked hackers that include email scams. In one instance, a fake email log-in page designed to steal passwords was sent to a top Gilead executive in legal and corporate affairs last month.
A lead intelligence researcher at Israeli cybersecurity firm ClearSky, which closely tracks Iranian hacking activity, Reuters that the attacks were part of an effort to compromise staff email accounts by using messages that impersonated journalists.that the Web domains and hosting servers used in the attacks were linked to Iran. The attempts represent a growing trend in which state-backed hackers have been gathering intelligence related to coronavirus and a possible treatment. Gilead is a ripe target for attacks, given that its antiviral drug remdesivir is the only treatment so far that has been shown in clinical trials to speed recovery for patients infected with the virus and was granted emergency-use authorization by the Food and Drug Administration last week.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Remdesivir emergency supplies to hospitals: Gilead coronavirus drug - Business InsiderHospitals are stuck waiting for supplies of a promising coronavirus treatment to arrive, days after health authorities OK'd its emergency use
Read more »
Japan approves Gilead Sciences' remdesivir as COVID-19 drugJapan has approved Gilead Sciences Inc's remdesivir as a treatment for COVID-19, the health ministry said on Thursday, making it the country's first officially authorized drug for the coronavirus disease.
Read more »
U.S. Doctors want details on federal distribution of Gilead coronavirus drugThe Infectious Disease Society of America (IDSA) is asking for more information on the federal government's plan for deciding how and where to supply the only drug so far shown to help patients infected with the novel coronavirus.
Read more »
Exclusive: Iran-linked hackers recently targeted coronavirus drugmaker Gilead - sourcesHackers linked to Iran have targeted staff at U.S. drugmaker Gilead Sciences Inc in recent weeks, according to publicly-available web archives reviewed by Reuters and three cybersecurity researchers, as the company races to deploy a treatment for the COVID-19 virus.
Read more »